Building AI-Ready Cultures in Life Sciences R&D - with Xiong Liu of Novartis

Summary

In this episode of the AI in Business podcast, Xiong Liu, Director of Data Science and AI at Novartis, discusses how generative AI and foundation models are reshaping life‑sciences R&D, from clinical workflows to collaborative research. He emphasizes the need for domain‑specific data strategies, higher data quality, and shared benchmarks to accelerate discovery and deliver measurable ROI in biopharma. Liu also shares practical examples of how Novartis is operationalizing AI to improve drug development speed and patient outcomes. The conversation frames AI adoption as a cultural shift that requires clear alignment with business goals and continuous learning across the organization.